RT Journal Article
SR Electronic
T1 742 Phase 1/2 study of the bispecific 4–1BB and PD-L1 antibody INBRX-105 alone and in combination with pembrolizumab in select solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A836
OP A837
DO 10.1136/jitc-2023-SITC2023.0742
VO 11
IS Suppl 1
A1 Park, Jong Chul
A1 Berz, David
A1 Sharma, Manish
A1 Massarelli, Erminia
A1 Hauke, Ralph J
A1 Tsai, Frank Yung-Chin
A1 Hong, David
A1 Akhave, Neal
A1 Call, Justin A
A1 Carlisle, Jennifer
A1 Sanborn, Rachel E
A1 Haas, Naomi B
A1 Hamm, John
A1 Ross Camidge, D
A1 Spira, Alexander I
A1 Andrianov, Vasily
A1 O’Neill, Brianne
A1 Kinkead, Heather
A1 Tolcher, Anthony W
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A836.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.